Recent

% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • mecosmo2 mecosmo2 Jan 9, 2014 12:53 PM Flag

    About GALE DD

    Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide. The company’s lead product candidate includes NeuVax (nelipepimut-S or E75), which is in Phase 3 clinical trials for preventing the recurrence of breast cancer. It also develops Folate Binding Protein-E39, a targeted vaccine that is in Phase 1/2 clinical trials for the prevention of recurrence in gynecological cancers, such as ovarian and endometrial adenocarconimas. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in Lake Oswego, Oregon.

    Sentiment: Buy

 
GALE
0.4202+0.0054(+1.30%)Aug 26 4:00 PMEDT